COVID-19 and immunosuppressive therapy in dermatology

被引：6
作者：
Schwartz, Robert A. [1 ]
Pradhan, Swetalina [2 ]
Murrell, Dedee F. [3 ]
Jafferany, Mohammad [4 ]
Olisova, Olga Y. [5 ]
Lomonosov, Konstantin M. [5 ]
Lotti, Torello [5 ,6 ]
Goldust, Mohamad [7 ,8 ]
机构：
[1] Rutgers New Jersey Med Sch, Dept Dermatol, Newark, NJ USA
[2] All India Inst Med Sci, Dept Dermatol & Venereol, Patna, Bihar, India
[3] Univ New South Wales, St George Hosp, Dept Dermatol, Fac Med, Sydney, NSW, Australia
[4] Cent Michigan Univ, Coll Med, Saginaw, MI USA
[5] IM Sechenov First Moscow State Med Univ, Dept Dermatol & Venereol, Moscow, Russia
[6] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy
[7] Univ Studies Guglielmo Marconi, Rome, Italy
[8] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland
来源：
DERMATOLOGIC THERAPY | 2020年 / 33卷 / 06期
关键词：
COVID; 19; dermatology; immunosuppressive therapy; ATOPIC-DERMATITIS; DIAGNOSIS;
D O I：
10.1111/dth.14140
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?
    Amerio, Paolo
    Giuliani, Federica
    Coppola, Marco
    Lobefaro, Fabio
    Gualdi, Giulio
    LIFE-BASEL, 2023, 13 (04):
  • [22] The impact of COVID-19 pandemic in dermatology outpatient clinics in Turkey: A survey study
    Ustaoglu, Eda
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (08) : 2382 - 2386
  • [23] Medical Student and Resident Dermatology Education in Canada During the COVID-19 Pandemic
    Ladha, Malika A.
    Lui, Harvey
    Carroll, Julia
    Doiron, Philip
    Kirshen, Carly
    Wong, Aaron
    Purdy, Kerri
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (04) : 437 - 442
  • [24] The effect of immunosuppressive therapy after liver transplantation on activities of daily living and fear of death during the COVID-19 pandemic
    Bulbuloglu, Semra
    Kapikiran, Gurkan
    TRANSPLANT IMMUNOLOGY, 2021, 69
  • [25] A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals
    Messas, Tassahil
    Lim, Rachel K.
    Burns, Laura
    Yumeen, Sara
    Kroumpouzos, George
    FRONTIERS IN MEDICINE, 2023, 10
  • [26] Organization of biologic therapy during the COVID-19 pandemic based on example of Dermatology Clinic Centre of Postgraduate Medical Education in Warsaw
    Dopytalska, Klaudia
    Mikucka-Wituszynska, Agata
    Ciechanowicz, Piotr
    Szczerba, Michal
    Szymanska, Elzbieta
    Walecka, Irena
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 864 - 868
  • [27] Recommendations Pediatric Dermatology Branch, Chilean Society of Pediatrics. COVID-19 pandemic
    Macias E, Ma Angelica
    Zapata G, Estela
    Gonzalez A, Ma Carolina
    Fuenzalidaa, Hector
    Honeyman, Juan
    Chavez, Francisco
    Chahuan, Marco
    Cordova, Hector
    Albornoz, Rodrigo
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2020, 91 (07): : 43 - 48
  • [28] Impact of the COVID-19 Pandemic on Canadian Dermatology Residents: A Cross Sectional Survey Study
    Bednar, E. Dimitra
    Doiron, Philip R.
    Abu-Hilal, Mohannad
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (03) : 325 - 326
  • [29] Dermatology outpatient clinic outcomes after COVID-19 outbreak: What is new normal?
    Caytemel, Ceyda
    Erdem, Ozan
    Agirgol, Senay
    Turkoglu, Zafer
    DERMATOLOGIC THERAPY, 2021, 34 (03)
  • [30] A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19
    Bieber, Thomas
    Feist, Eugen
    Irvine, Alan D.
    Harigai, Masayoshi
    Haladyj, Ewa
    Ball, Susan
    Deberdt, Walter
    Issa, Maher
    Grond, Susanne
    Taylor, Peter C.
    ADVANCES IN THERAPY, 2022, 39 (11) : 4910 - 4960
12345